October 9-20, 2016
42 participants, 20 women, 22 men from 22 countries
Faculty
C. Arias, University of Texas, USA; D. Bikard, Institut Pasteur, France; E. Bœttger, Universität Zürich, Switzerland; E. Brown, McMaster University, Canada; R. Cantón, University Hospital Ramon y Cajal, Spain; A. Carattoli, Instituto Superiore di Sanità, Italy; M. Chandler, Université Paul Sabatier, France; J.‑P. Charrier, bioMérieux, France; J. M. Chatel, INRA, France; G. Dale, Polyphor Ltd. , Switzerland; L. Debarbieux, Institut Pasteur, France; J.‑D. Docquier, University of Siena, Italy; T. Dougherty, Harvard Medical School, USA; J.‑M. Frere, University of Liège, Belgium; H. Goossens, University of Antwerp, Belgium; R. Hancock, University of British Columbia, Canada; D. Hooper, Massachusetts General Hospital, USA; D. Hughes, Uppsala University, Sweden; J.‑Y. Madec, ANSES, France; A. Mankin, University of Illinois, USA; H. Moser, Novartis, USA; A. Myers, Harvard University, USA; S. Nwaka, WHO, Switzerland; M. Page, Basel, Switzerland; K. Pos, Goethe University, Germany; S. Projan, MedImmune, USA; M. Pucci, Spero Therapeutics, USA; C. Pulcini, Université de Lorraine, France; D. Rasko, University of Maryland School of Medicine, USA; G. M Rossolini, University of Siena, Italy; H.‑G. Sahl, University of Bonn, Germany; A. van Belkum, bioMérieux, France; E. Varon, HEGP, France; C. Voigt, Massachusetts Institute of Technology, USA; T. Walsh, Cardiff University, UK; D. Wilson, University of Oxford, UK; G. Wright, McMaster University, Canada; H. Zgurskaya, University of Oklahoma, USA